-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: keymaster@town.hall.org
Originator-Key-Asymmetric:
 MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq
 pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ==
MIC-Info: RSA-MD5,RSA,
 kGlhUiOSVnUiaBvvppITUfY4vI+eofkBzdUtX7K/smqBUaNoNYtnGQr5qHuzRec4
 8VCbU5gkMjsMSS8oy5V3Qg==

<IMS-DOCUMENT>0000950131-95-001556.txt : 19950609
<IMS-HEADER>0000950131-95-001556.hdr.sgml : 19950609
ACCESSION NUMBER:		0000950131-95-001556
CONFORMED SUBMISSION TYPE:	10-C
CONFIRMING COPY:	
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	19950515
FILED AS OF DATE:		19950608
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-C
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		00000000

	BUSINESS ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217
		BUSINESS PHONE:		5032833911

	MAIL ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</IMS-HEADER>
<DOCUMENT>
<TYPE>10-C
<SEQUENCE>1
<DESCRIPTION>FORM 10-C
<TEXT>

<PAGE>
 
             This is a confirming electronic copy of the Form 10-C
                        filed manually on May 24, 1995.

                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 10-C

                    REPORT BY ISSUER OF SECURITIES QUOTED ON
                      NASDAQ INTERDEALER QUOTATION SYSTEM
                     FILED PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934
                      AND RULE 13a-17 OR 15d-17 THEREUNDER


                            OXIS INTERNATIONAL, INC.
- --------------------------------------------------------------------------------
                 (EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER)


             6040 N. Cutter Circle, Suite 317, Portland, OR  97217
- --------------------------------------------------------------------------------
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

Issuer's telephone number, including area code:   (503) 283-3911
                                                 -----------------

                  I.   CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:

1.  Title of security    Common Stock
                     -----------------------------------------------------------

2.  Number of shares outstanding before the change     9,322,762
                                                  ------------------------------

3.  Number of shares outstanding after the change        10,590,387
                                                 -------------------------------

4.  Effective date of change        May 19, 1995
                            ----------------------------------------------------

5.  Method of change:  Specify method (such as merger, acquisition, exchange,
    distribution, stock split, reverse split, acquisition of stock for treasury,
    etc.)

       Issuance and Sale of Common Stock in Private Placement
- --------------------------------------------------------------------------------

Give brief description of transaction:   On May 17, 1995 and May 19, 1995, OXIS
International, Inc. ("OXIS") sold 1,227,625 shares of its Common Stock in a
private placement to offshore investors for an aggregate consideration of
$2,037,860.  The Common Stock sold has not been registered under the Securities
Act of 1933, and may not be re-offered or re-sold absent registration under the
Securities Act or available exemptions from such registration requirements.
<PAGE>
 
On May 17, 1995, 40,000 shares of the Company's Series A Preferred Stock
automatically converted to Common Stock in accordance with the terms of the
Certificate of Designation of the Company's Series A Preferred Stock.
<PAGE>
 
                                   SIGNATURE



Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                              OXIS International, Inc.



Date:   May 23, 1995                  By:       /s/  Ray R. Rogers         
            ---                                 --------------------         
                                                Name:  Ray R. Rogers         
                                                Title:  Chairman of the Board 
</TEXT>
</DOCUMENT>
</IMS-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
